IRIS Accounts Production v24.1.9.2 07816557 Board of Directors Board of Directors 1.1.24 31.1.25 31.1.25 true false true false false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 Ordinary E 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh078165572023-12-31078165572025-01-31078165572024-01-012025-01-31078165572023-02-28078165572023-03-012023-12-31078165572023-12-3107816557ns15:EnglandWales2024-01-012025-01-3107816557ns14:PoundSterling2024-01-012025-01-3107816557ns10:Director12024-01-012025-01-3107816557ns10:Director22024-01-012025-01-3107816557ns10:PrivateLimitedCompanyLtd2024-01-012025-01-3107816557ns10:SmallEntities2024-01-012025-01-3107816557ns10:AuditExempt-NoAccountantsReport2024-01-012025-01-3107816557ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012025-01-3107816557ns10:SmallCompaniesRegimeForAccounts2024-01-012025-01-3107816557ns10:FullAccounts2024-01-012025-01-310781655712024-01-012025-01-3107816557ns10:OrdinaryShareClass12024-01-012025-01-3107816557ns10:OrdinaryShareClass22024-01-012025-01-3107816557ns10:OrdinaryShareClass32024-01-012025-01-3107816557ns10:OrdinaryShareClass42024-01-012025-01-3107816557ns10:OrdinaryShareClass52024-01-012025-01-3107816557ns10:Director32024-01-012025-01-3107816557ns10:CompanySecretary12024-01-012025-01-3107816557ns10:RegisteredOffice2024-01-012025-01-3107816557ns5:CurrentFinancialInstruments2025-01-3107816557ns5:CurrentFinancialInstruments2023-12-3107816557ns5:ShareCapital2025-01-3107816557ns5:ShareCapital2023-12-3107816557ns5:SharePremium2025-01-3107816557ns5:SharePremium2023-12-3107816557ns5:RetainedEarningsAccumulatedLosses2025-01-3107816557ns5:RetainedEarningsAccumulatedLosses2023-12-3107816557ns5:IntangibleAssetsOtherThanGoodwill2024-01-012025-01-3107816557ns5:PatentsTrademarksLicencesConcessionsSimilar2024-01-012025-01-3107816557ns5:PlantMachinery2024-01-012025-01-3107816557ns5:ComputerEquipment2024-01-012025-01-3107816557ns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-3107816557ns5:PatentsTrademarksLicencesConcessionsSimilar2025-01-3107816557ns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-3107816557ns5:PlantMachinery2023-12-3107816557ns5:ComputerEquipment2023-12-3107816557ns5:PlantMachinery2025-01-3107816557ns5:ComputerEquipment2025-01-3107816557ns5:PlantMachinery2023-12-3107816557ns5:ComputerEquipment2023-12-3107816557ns5:CostValuation2023-12-3107816557ns5:DisposalsRepaymentsInvestments2025-01-3107816557ns5:CostValuation2025-01-3107816557ns5:Subsidiary12024-01-012025-01-3107816557ns5:Subsidiary112024-01-012025-01-3107816557ns5:Subsidiary12025-01-3107816557ns5:Subsidiary12023-12-3107816557ns5:Subsidiary12023-12-3107816557ns5:Subsidiary12023-03-012023-12-3107816557ns5:Non-currentFinancialInstruments2025-01-3107816557ns5:Non-currentFinancialInstruments2023-12-3107816557ns5:CurrentFinancialInstruments2024-01-012025-01-3107816557ns10:OrdinaryShareClass12025-01-3107816557ns10:OrdinaryShareClass22025-01-3107816557ns10:OrdinaryShareClass32025-01-3107816557ns10:OrdinaryShareClass42025-01-3107816557ns10:OrdinaryShareClass52025-01-31
REGISTERED NUMBER: 07816557 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD

1 JANUARY 2024 TO 31 JANUARY 2025

FOR

INTENSICHEM GROUP LIMITED

INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


INTENSICHEM GROUP LIMITED

COMPANY INFORMATION
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025







DIRECTORS: Mr O A A Tames
Mr M P Smith BA (Hons) FCA
Mr J M Tiley





SECRETARY: Mrs V A Smith ACA FCCA





REGISTERED OFFICE: 4 Kings Row
Armstrong Road
Maidstone
Kent
ME15 6AQ





REGISTERED NUMBER: 07816557 (England and Wales)





ACCOUNTANTS: Mackenzies Accountants Limited
Chartered Accountants
1 Langley Court
Pyle Street
Newport
Isle of Wight
PO30 1LA

INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557)

BALANCE SHEET
31 JANUARY 2025

2025 2023
Notes £ £ £ £
FIXED ASSETS
Intangible assets 4 84,499 70,828
Tangible assets 5 1,073 1,471
Investments 6 - 200
85,572 72,499

CURRENT ASSETS
Debtors 7 4,175 341,872
Cash at bank 1 1
4,176 341,873
CREDITORS
Amounts falling due within one year 8 62 344
NET CURRENT ASSETS 4,114 341,529
TOTAL ASSETS LESS CURRENT
LIABILITIES

89,686

414,028

CAPITAL AND RESERVES
Called up share capital 9 35,594 35,594
Share premium 454,332 454,332
Retained earnings (400,240 ) (75,898 )
SHAREHOLDERS' FUNDS 89,686 414,028

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557)

BALANCE SHEET - continued
31 JANUARY 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 February 2025 and were signed on its behalf by:




Mr O A A Tames - Director



Mr J M Tiley - Director


INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025


1. STATUTORY INFORMATION

Intensichem Group Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 25% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 4 (2023 - 4 ) .

4. INTANGIBLE FIXED ASSETS
Patents and
licences
£
COST
At 1 January 2024 121,406
Additions 29,255
At 31 January 2025 150,661
AMORTISATION
At 1 January 2024 50,578
Amortisation for period 15,584
At 31 January 2025 66,162
NET BOOK VALUE
At 31 January 2025 84,499
At 31 December 2023 70,828

INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025


4. INTANGIBLE FIXED ASSETS - continued

The intangible asset is the granted United Kingdom patent number 10960373, which relates to the invention of a continuous flow hydrogenation process and process apparatus. During February 2025 the company granted a licence to Intensichem Solutions Limited, a company controlled by Oliver Tames and John Tiley, allowing that company to use the said patent in return for a royalty of 30%, payable to the company, of the net sales value deriving from all patent exploitative products, sold or otherwise supplied for money or money's worth.

This licence replaced a similar agreement between the company and Intensichem Limited, a wholly owned subsidiary, which subsequent to the period end, during February 2025, entered into liquidation.

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£ £ £
COST
At 1 January 2024
and 31 January 2025 30,473 2,774 33,247
DEPRECIATION
At 1 January 2024 29,136 2,640 31,776
Charge for period 362 36 398
At 31 January 2025 29,498 2,676 32,174
NET BOOK VALUE
At 31 January 2025 975 98 1,073
At 31 December 2023 1,337 134 1,471

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£
COST
At 1 January 2024 200
Disposals (200 )
At 31 January 2025 -
NET BOOK VALUE
At 31 January 2025 -
At 31 December 2023 200

INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025


6. FIXED ASSET INVESTMENTS - continued

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Intensichem Limited
Registered office: 4 Kings Row, Armstrong Road, Maidstone, Kent. ME15 6AQ
Nature of business: Pharmaceutical and chemical process R&D
%
Class of shares: holding
Ordinary 100.00
31.1.25 31.12.23
£ £
Aggregate capital and reserves (377,543 ) (351,001 )
Loss for the period (26,542 ) (30,016 )

The company's wholly owned subsidiary, Intensichem Limited ceased trading on 31st January 2025 and subsequent to the period end, during February 2025, it entered liquidation. The directors consider that the company's investment in Intensichem Limited has no value and it has been written off in these accounts.

7. DEBTORS
2025 2023
£ £
Amounts falling due within one year:
Other debtors 4,175 4,075

Amounts falling due after more than one year:
Amounts owed by group undertakings - 337,797

Aggregate amounts 4,175 341,872

The amount previously shown as due after more than year, related to an amount owed to the company by the wholly subsidiary, Intensichem Limited. Intensichem Limited ceased trading on 31st January 2025 and has subsequently entered liquidation, the directors consider that the balance owed to the company is irrecoverable and it has been written off in these accounts.

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2023
£ £
Other creditors 62 344

Other creditors comprises of a company credit card balance.

INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025


9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2023
value: £ £
3,146 Ordinary A £1 3,146 3,146
7,934 Ordinary B £1 7,934 7,934
786 Ordinary C £1 786 786
786 Ordinary D £1 786 786
22,231 Ordinary E £1 22,231 22,231
711 Ordinary F £1 711 711
35,594 35,594

10. RELATED PARTY DISCLOSURES

During the period Intensichem Limited, a wholly owned subsidiary company made payments on behalf of the company. These transactions are recorded through an intercompany account and, as at the balance sheet date, the amount owed by Intensichem Limited was £308,260 (YE Dec-23: £337,797).

Intensichem Limited ceased trading on 31st January 2025 and subsequent to the period end, during February 2025, it entered liquidation. The directors consider that the balance due from Intensichem Limited is irrecoverable and has been written off in these accounts.

Intensichem Limited, a wholly owned subsidiary, benefited from a licence granted by the company, under United Kingdom Patent No 10960373, relating to the invention of a continuous flow hydrogenation process and process apparatus. The licence permitted Intensichem Limited to use the said patent in return for a royalty of 30%, payable to the company, of the net sales value deriving from all patent exploitative products, sold or otherwise supplied for money or money's worth. Intensichem Limited's use of the patent has remained in the research and development phase, and to date no such income has arisen.

Subsequent to the period end, during February 2025, Intensichem Limited entered liquidation, and the company has granted a similar licence to Intensichem Solutions Limited, a company controlled by Oliver Tames and John Tiley.

During the period, Mackenzies Chartered Accountants provided services to the group and these are disclosed fully in the notes of the subsidiary company, Intensichem Limited. One of the directors of Mackenzies holds a 2.5% interest in the share capital of the company.

11. ULTIMATE CONTROLLING PARTY

No individual is the ultimate controlling party. The shareholders among themselves hold the entire share capital of the company.